Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Direct observations: clinical cases, poisoning incidents and other

Currently viewing:

Administrative data

Endpoint:
direct observations: clinical cases, poisoning incidents and other
Type of information:
migrated information: read-across from supporting substance (structural analogue or surrogate)
Adequacy of study:
supporting study
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
Reasonably well-documented publication. In this study, intestinal absorption of magnesium was studied in human volunteers receiving magnesium controlled diet, from which magnesium can be assumed to be well bioavailable. The data are used for read-across from a supporting substance for evaluating oral absorption.
Cross-reference
Reason / purpose for cross-reference:
reference to same study

Data source

Reference
Reference Type:
publication
Title:
Magnesium absorption and metabolism in patients with chronic renal failure and in patients with normal renal function
Author:
Spencer, H. et al.
Year:
1980
Bibliographic source:
Gastroenterology 79, 26-34

Materials and methods

Study type:
study with volunteers
Endpoint addressed:
basic toxicokinetics
Test guideline
Qualifier:
according to guideline
Guideline:
other: DHEW (Department of Health, Education, & Welfare) guidelines
Principles of method if other than guideline:
Toxicokinetics in humans
Oral bioavailability of dietary magnesium
GLP compliance:
no

Test material

Constituent 1
Reference substance name:
Magnesium
EC Number:
231-104-6
EC Name:
Magnesium
Cas Number:
7439-95-4
IUPAC Name:
magnesium
Details on test material:
- Name of test material (as cited in study report): Magnesium
- Source: Dietary, i.e. from natural sources, strictly controlled
No further details are given.

Method

Type of population:
general
Subjects:
- Number of subjects exposed: 8
- Sex: male
- Age: 47-67 years
- Known diseases: Chronic renal failure; subjects were in good physical condition and had normal gastrointestinal and liver function
- Other: The serum levels of creatinine were elevated, ranging from 2.4 to 14.6 mg/100 ml, as were the levels of blood urea nitrogen (BUN), which ranged from 26 to 106 mg/100 ml. The creatinine clearance ranged from 5 to 54 ml/minute.
- Control subjects (normal renal function): 10 age matched patients
No further details are given.
Ethical approval:
confirmed and informed consent free of coercion received
Remarks:
In compliance with DHEW guidelines (United States Department of Health, Education, and Welfare).
Route of exposure:
oral
Reason of exposure:
intentional
Exposure assessment:
measured
Details on exposure:
Sixteen Mg balance studies were carried out under strictly controlled dietary conditions in the Metabolic Research Ward. 10 of these studies were carried out during a low Mg intake averaging 159 mg/day and a low Ca intake averaging 200 mg/day, and 6 were carried out during similar dietary Mg intake but during different Ca intakes ranging from 800-2000 mg/day. 33 control studies were carried out.
The duration of the studies of the patients with chronic renal failure averaged 28 days during the low Ca intake and 72 days during the higher Ca intakes. Patients received diets containing 172 mg Mg.
Examinations:
Urine and stool specimens were collected. The body weight, 24-hour urine volume, and urinary excretion of creatinine were determined daily. Metabolic balances of Mg were determined in each 6-day study period on aliquots of the diet and on aliquots of 6-day collection pools of urine and stool. Mg and Ca in the diet, urine, stool and serum were determined by atomic absorption spectroscopy.
Medical treatment:
no medication

Results and discussion

Clinical signs:
no data
Results of examinations:
The average net absorption of Mg of patients with chronic renal failure was significantly lower (17 % of magnesium intake) than the absorption of patients with normal renal function (48.5 %). The lower absorption of Mg of patients with chronic renal failure was due to the significantly higher faecal Mg excretion, averaging 82.5 % of the Mg intake, compared with an average of 51.5 % for patients with normal renal function.
The faecal/urinary Mg excretion ratio for patients with normal renal function was close to 1.0, whereas it averaged 1.75 for patients with chronic renal failure, which indicates a shift of the Mg excretion from the kidney to the intestine.
The Mg balance did not differ significantly from that of age-matched patients with normal kidney function receiving similar or higher Mg intake. In a long-term study of a patient with chronic renal failure, the net absorption of Mg was greater during a higher Mg intake than during the lower Mg intake. The Mg absorption was only half the value, 24 % vs 48 %, for patients with normal renal function receiving the same Mg intake. Increasing the Ca intake from 200 to 800, 1400, and 2000 mg/day did not change the Mg balance or the net absorption of Mg of patients with chronic renal failure and of patients with normal renal function.
Effectivity of medical treatment:
Not applicable - no medication received.
Outcome of incidence:
no data

Applicant's summary and conclusion

Conclusions:
In healthy subjects, absorption of magnesium from the diet was found to be approximately 50 %.